Drug Trial Radar · NCT01897532
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
Last checked: Nov 19, 2026Latest source record: Apr 4, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
6,991
Actual
Start
Jul 10, 2013
Primary completion
Jan 18, 2018
Study completion Jan 18, 2018
Sponsor
- Lead sponsor
- Boehringer IngelheimBoehringer Ingelheim
- Sponsor type
- Industry
- Collaborators
- Eli Lilly and Company
- First posted
- Jul 12, 2013
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of the study is to investigate the longterm impact on cardiovascular morbidity, mortality and renal function of treatment with linagliptin in a selected population of patients with Type 2 diabetes mellitus (T2DM) and to compare outcomes against placebo, on a background of standard of care.
Conditions
- Diabetes Mellitus, Type 2
Interventions
PlaceboDrug
placebo matching tablets
LinagliptinDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to the First Occurrence of Any of the Following Adjudication-confirmed Components of the Primary Composite Endpoint 3-point Major Adverse Cardiovascular (CV) Events (3-point MACE): CV Death, Non-fatal Myocardial Infarction (MI) or Non-fatal Stroke.Time frame: From randomization to individual end of observation; up to 4.3 years
Locations
649 sites in 27 countries. Site status is shown where the registry gives one.
Longwood Research
Huntsville, Alabama
Scottsboro Quick Care Clinic
Scottsboro, Alabama
Office of Dr. Terence T. Hart MD
Tuscumbia, Alabama
Arrowhead Health Centers
Glendale, Arizona
Precision Trials, LLC
Phoenix, Arizona
Harrisburg Family Medical Center
Harrisburg, Arkansas
Cardiology and Medicine Clinic
Little Rock, Arkansas
Little Rock Diagnostic Clinic
Little Rock, Arkansas
Kaiser Permanente - San Diego, Bonita
Bonita, California
John Muir Physician Network Clinical Research Center
Concord, California
Valley Research
Fresno, California
VA Loma Linda Healthcare System
Loma Linda, California
Long Beach Center for Clinical Research
Long Beach, California
Clearview Medical Research, LLC
Los Angeles, California
National Research Institute
Los Angeles, California
Office of Dr. Richard S. Cherlin
Los Gatos, California
Coastal Medical Research Group
Los Osos, California
Novo Research, Incorporated
Modesto, California
Providence Clinical Research
North Hollywood, California
Northridge Clinical Research Inc.
Northridge, California
Carr Cardiology
Oceanside, California
Center for Clinical Trials of Sacramento, Incorporated
Sacramento, California
North America Research Institute
San Dimas, California
Trinitas Research, Incorporated
San Jose, California
Metabolic Institute of America
Tarzana, California
Center for Clinical Trials of San Gabriel
West Covina, California
Western Nephrology & Metabolic
Arvada, Colorado
South Denver Nephrology
Denver, Colorado
Colorado Center for Bone Research, P.C.
Golden, Colorado
Helix Biomedics LLC
Boynton Beach, Florida
Orthopedic Research Institute
Boynton Beach, Florida
Nova Clinical Research, LLC
Bradenton, Florida
PAB Clinical Research
Brandon, Florida
Meridien Research
Brooksville, Florida
Southeast Clinical Research, LLC
Chiefland, Florida
BayCare Medical Group
Clearwater, Florida
Cohen Medical Research Associates, LLC
Delray Beach, Florida
Innovation Medical Research Center, Inc
Doral, Florida
Integrative Research Associates
Fort Lauderdale, Florida
Jellinger and Lerman, MD, PA dba The Center for Diabetes and Endocrine Care
Fort Lauderdale, Florida
Showing 40 of 649 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.